MBRX Moleculin Biotech Inc
Company Analysis
Latest News
🔴 MBRX is trading 5% down today after interim cancer trial data falls short of statistical significance
• MBRX shares plunged after the company announced interim results from its Phase 2/3 MIRACLE trial for Annamycin in relapsed or refractory acute myeloid...
Moleculin Biotech raises approximately $2.7 million from recent warrant exercises
Moleculin Biotech, Inc. announced it received approximately $2.7 million in gross proceeds from the exercise of warrants subsequent to its last quarterly...
Moleculin Reports Positive Interim Phase 2/3 Data for Annamycin in AML Trial
Moleculin Biotech, Inc. (MBRX) announced positive preliminary efficacy results from its pivotal Phase 2/3 MIRACLE trial for Annamycin in treating relapsed or...
🔴 MBRX Plunges 17.5% Despite Positive MIRACLE Trial Data, as Dilution Concerns and Profit-Taking Weigh
MBRX is trading 17.5% down at $2.94 today. • This decline occurs despite Moleculin Biotech announcing positive preliminary unblinded efficacy results from its...
Moleculin's $8.3 Million Cash Grab Came With a Catch — Can a Micro-Cap Biotech Survive Doubling Its Share Count?
Shares of Moleculin Biotech (MBRX) plunged 19.4% to $2.88 as the lingering shadow of a February 2026 warrant deal continues to crush investor confidence. The...
🔴 MBRX is trading 19.4% down today after $2.7M warrant exercises
• Moleculin Biotech reported warrant exercises for 1,361,500 shares, generating approximately $2.7 million in gross proceeds, as of June 29, 2026. • The...
🔴 MBRX is trading 5.3% down today on profit-taking after a 20% weekly rally
MBRX is trading 5.3% down at $3.38 as investors lock in gains following a significant multi-day run-up. • Shares had climbed more than 20% over the past week...
🟢 MBRX makes sharp 10.4% jump
MBRX is trading at $3.61, up 10.4% versus the comparison close of $3.27 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MBRX is trading 6.1% up today as shares extend recent clinical data momentum
MBRX is trading at $3.47 (up 6.1%) as the stock continues to build on recent clinical data momentum and broader strength in the biotech sector. • The move...
🟢 MBRX makes sharp 13.5% jump
MBRX is trading at $3.71, up 13.5% versus the comparison close of $3.27 during pre-market. This is a price-movement alert; no separate company-specific...